Dallas Principal William Ellerman was quoted in Technology Transfer Tactics discussing the significance of Baylor winning a licensing dispute against health tech company Hemotek and how other universities can protect themselves from facing these legal battles to begin with, saying that “universities should have strong and specific language about what it means for a licensee to commercialize in order to fulfill that obligation.” He added that “when you specifically define things, it makes it less subject to interpretation, and less likely that the licensee is going to have a viable counterclaim if a license is terminated.” However, he noted that language favoring the university too strongly – such as the option to terminate a license at any time – is not typical or advisable, and that tech transfer programs should strike a balance with license expectations and termination.

Click here to read the article.

Jump to Page